142 related articles for article (PubMed ID: 4146043)
21. Management of the schizophrenic patient in a community psychiatric practice.
Tobin JM
Dis Nerv Syst; 1968 May; 29(5):Suppl:27-34. PubMed ID: 4876987
[No Abstract] [Full Text] [Related]
22. [Dynamics and treatment of the tendency to enchronization of schizophrenic psychoses].
López-Ibor Aliño JM
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1973; 1(2):377-88. PubMed ID: 4147379
[No Abstract] [Full Text] [Related]
23. Effect of trifluperidol (R 2498) on the urinary elimination of bufotenin in schizophrenia.
Acebal EM; Spatz H
Int J Neuropsychiatry; 1967 Dec; 3(6):472-6. PubMed ID: 5583441
[No Abstract] [Full Text] [Related]
24. [Clinical evaluation of pimozide].
Fortini K; Losieczko T
Psychiatr Pol; 1971; 5(4):429-31. PubMed ID: 5112319
[No Abstract] [Full Text] [Related]
25. Incisive neuroleptic drugs in child psychiatry.
Stárková L; Mrna B
Act Nerv Super (Praha); 1989 Jun; 31(2):120. PubMed ID: 2572132
[No Abstract] [Full Text] [Related]
26. [Pilot study on oxaflumazine, a new piperazinated phenothiazine].
Villeneuve A; Dogan K; Lachance R; Drolet A
Int J Clin Pharmacol; 1972 Aug; 6(3):246-55. PubMed ID: 4405378
[No Abstract] [Full Text] [Related]
27. Pilot clinical study with trifluperidol (Trisedyl) therapy in psychotic patients.
Dolezalová V; Faltus F; Soucek K
Act Nerv Super (Praha); 1974 Aug; 16(3):171. PubMed ID: 4609154
[No Abstract] [Full Text] [Related]
28. [Treatment of schizophrenic patients with triperidol (trisedil)].
Ezhkov AA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1394-400. PubMed ID: 5705722
[No Abstract] [Full Text] [Related]
29. Clinical effectiveness of piperacetazine injection in schizophrenic patients: a controlled study.
Kulkarni AS
Adv Biochem Psychopharmacol; 1974; 9(0):691-9. PubMed ID: 4151770
[No Abstract] [Full Text] [Related]
30. Fluspirilene and pipothiazine undecylenate, two long-acting injectable neuroleptics. A double-blind controlled trial in residual schizophrenia.
Vereecken JL; Tanghe A
Psychiatr Neurol Neurochir; 1972; 75(2):117-27. PubMed ID: 5030483
[No Abstract] [Full Text] [Related]
31. Evaluation of clinical efficacy of pimozide as maintenance therapy in chronic schizophrenic patients.
Singh AN
Curr Ther Res Clin Exp; 1971 Nov; 13(11):695-705. PubMed ID: 5000717
[No Abstract] [Full Text] [Related]
32. Sertindole, a new atypical antipsychotic for the treatment of schizophrenia.
Brown LA; Levin GM
Pharmacotherapy; 1998; 18(1):69-83. PubMed ID: 9469684
[TBL] [Abstract][Full Text] [Related]
33. Pimozide: use in dermatology.
van Vloten WA
Dermatol Online J; 2003 Mar; 9(2):3. PubMed ID: 12639456
[TBL] [Abstract][Full Text] [Related]
34. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
Cutler AJ; Kalali AH; Weiden PJ; Hamilton J; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S20-8. PubMed ID: 18334909
[TBL] [Abstract][Full Text] [Related]
35. [Clinical results with trifluoperidol in schizophrenic patients].
Navarro MP; Assis LM; Martins C
Rev Assoc Med Bras; 1966 Dec; 12(12):497-501. PubMed ID: 5241539
[No Abstract] [Full Text] [Related]
36. A double-blind comparison of pimozide with carpipramine in schizophrenic patients.
Kudo Y
Acta Psychiatr Belg; 1972 Nov; 72(6):685-97. PubMed ID: 4606115
[No Abstract] [Full Text] [Related]
37. Pimozide (orap, R 6238) in residual schizophrenia. A clinical evaluation with long-term double-blind follow-up.
Denijs EL; Vereecken JL
Psychiatr Neurol Neurochir; 1973; 76(1):47-59. PubMed ID: 4699105
[No Abstract] [Full Text] [Related]
38. Pimozide versus chlorpromazine in chronic schizophrenia: a 52 week double-blind study of maintenance therapy.
Wilson LG; Roberts RW; Gerber CJ; Johnson MH
J Clin Psychiatry; 1982 Feb; 43(2):62-5. PubMed ID: 7035441
[TBL] [Abstract][Full Text] [Related]
39. Classification of neuroleptics based on their pharmacokinetics.
Dahl SG
Clin Neuropharmacol; 1986; 9 Suppl 4():409-11. PubMed ID: 2882845
[No Abstract] [Full Text] [Related]
40. New advances in the treatment of schizophrenia. Introduction.
Potkin SG
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S1-3. PubMed ID: 18334907
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
